Your browser is no longer supported. Please, upgrade your browser.
Settings
GH [NASD]
Guardant Health, Inc.
Index- P/E- EPS (ttm)-3.77 Insider Own3.60% Shs Outstand101.17M Perf Week1.44%
Market Cap10.92B Forward P/E- EPS next Y-3.34 Insider Trans-3.29% Shs Float96.79M Perf Month-18.66%
Income-378.60M PEG- EPS next Q-0.96 Inst Own90.70% Short Float4.78% Perf Quarter-11.87%
Sales323.70M P/S33.73 EPS this Y-211.70% Inst Trans0.11% Short Ratio5.11 Perf Half Y-31.24%
Book/sh7.79 P/B13.49 EPS next Y14.80% ROA-18.50% Target Price167.39 Perf Year2.26%
Cash/sh17.24 P/C6.09 EPS next 5Y12.60% ROE-37.60% 52W Range96.66 - 181.07 Perf YTD-18.48%
Dividend- P/FCF- EPS past 5Y- ROI-12.10% 52W High-41.98% Beta-
Dividend %- Quick Ratio19.30 Sales past 5Y- Gross Margin66.50% 52W Low8.69% ATR5.45
Employees864 Current Ratio19.60 Sales Q/Q38.90% Oper. Margin- RSI (14)40.86 Volatility4.40% 5.00%
OptionableYes Debt/Eq0.00 EPS Q/Q-69.50% Profit Margin- Rel Volume1.83 Prev Close99.44
ShortableYes LT Debt/Eq1.44 EarningsNov 04 AMC Payout- Avg Volume905.00K Price105.06
Recom1.50 SMA20-7.40% SMA50-9.67% SMA200-20.87% Volume1,659,446 Change5.65%
Oct-15-21Resumed Cowen Outperform $170
Jun-15-21Initiated Raymond James Mkt Perform
Jun-03-21Initiated Goldman Buy $160
May-25-21Initiated Wells Fargo Overweight $145
Jan-11-21Initiated Stifel Buy $175
Sep-09-20Initiated Morgan Stanley Overweight $110
Jun-12-20Initiated BTIG Research Buy
Feb-21-20Initiated Guggenheim Buy $103
Jan-07-20Initiated Citigroup Buy $100
Aug-07-19Reiterated Canaccord Genuity Buy $96 → $125
Apr-16-19Initiated Canaccord Genuity Buy $90
Apr-10-19Upgrade BofA/Merrill Neutral → Buy $81 → $84
Feb-28-19Reiterated BofA/Merrill Neutral $42 → $60
Oct-29-18Initiated William Blair Outperform
Oct-29-18Initiated JP Morgan Overweight $42
Oct-29-18Initiated BofA/Merrill Neutral $37
Oct-08-21 08:05AM  
Oct-05-21 08:05AM  
Oct-04-21 12:04PM  
Oct-03-21 10:40AM  
Oct-01-21 01:13PM  
12:41PM  
09:40AM  
Sep-30-21 06:13AM  
Sep-27-21 11:45AM  
Sep-17-21 12:00AM  
Sep-15-21 04:00AM  
Sep-08-21 01:34PM  
Sep-07-21 08:05AM  
Sep-02-21 04:05PM  
Aug-31-21 12:07AM  
Aug-18-21 02:23PM  
Aug-17-21 09:25PM  
Aug-12-21 01:05PM  
Aug-11-21 04:30AM  
Aug-06-21 04:15PM  
10:30AM  
09:35AM  
Aug-05-21 06:35PM  
04:05PM  
04:03PM  
Aug-01-21 05:52AM  
Jul-29-21 03:05PM  
Jul-19-21 06:38PM  
09:30AM  
Jul-13-21 08:05AM  
Jul-05-21 03:42AM  
Jun-30-21 11:17AM  
Jun-25-21 12:28PM  
Jun-23-21 01:25PM  
Jun-22-21 08:05AM  
Jun-18-21 08:23PM  
07:57PM  
Jun-08-21 08:05AM  
Jun-04-21 09:10AM  
May-28-21 01:15PM  
01:52AM  
May-22-21 06:11AM  
May-21-21 03:14PM  
May-20-21 04:17PM  
03:51PM  
08:05AM  
May-15-21 06:39AM  
May-13-21 06:16AM  
May-07-21 06:00AM  
May-06-21 06:50PM  
May-04-21 04:02PM  
May-03-21 08:05AM  
Apr-29-21 05:06PM  
08:05AM  
Apr-27-21 08:05AM  
Apr-24-21 06:12AM  
Apr-12-21 04:05PM  
07:26AM  
Apr-10-21 08:35AM  
Apr-06-21 11:11AM  
05:05AM  
Apr-01-21 11:05AM  
08:05AM  
06:57AM  
Mar-30-21 08:05AM  
Mar-26-21 08:05AM  
Mar-25-21 07:01AM  
Mar-24-21 08:05AM  
Mar-23-21 10:02AM  
Mar-21-21 07:33AM  
Mar-13-21 07:18AM  
Mar-04-21 03:21PM  
Mar-03-21 08:17AM  
Mar-02-21 08:05AM  
Mar-01-21 09:20AM  
Feb-25-21 11:34AM  
06:04AM  
12:30AM  
Feb-24-21 04:29PM  
04:05PM  
Feb-23-21 10:24AM  
Feb-21-21 06:17AM  
06:12AM  
Feb-17-21 04:03PM  
Feb-16-21 08:05AM  
Feb-12-21 06:01AM  
Feb-05-21 05:52AM  
Feb-04-21 04:03PM  
Feb-03-21 06:10AM  
Jan-29-21 06:08AM  
Jan-27-21 08:05AM  
Jan-25-21 06:01AM  
Jan-18-21 03:00AM  
Jan-14-21 08:05AM  
Jan-13-21 07:25AM  
Jan-07-21 01:18PM  
Jan-06-21 02:47AM  
Dec-30-20 04:03PM  
Dec-27-20 07:31AM  
Dec-24-20 10:21AM  
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing tests from its LUNAR program for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; LUNAR-2 test for the early detection of cancer in asymptomatic individuals eligible for cancer screening; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for residual disease and recurrence monitoring; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Daiichi Sankyo has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERESMAN STANLEY JDirectorOct 11Option Exercise5.944,93429,3088,993Oct 13 05:03 PM
MERESMAN STANLEY JDirectorOct 11Sale103.594,934511,1134,059Oct 13 05:03 PM
MERESMAN STANLEY JDirectorSep 10Option Exercise5.944,93429,3088,993Sep 14 05:07 PM
MERESMAN STANLEY JDirectorSep 10Sale129.784,934640,3314,059Sep 14 05:07 PM
CLARK IAN TDirectorSep 01Option Exercise4.181,0764,4981,076Sep 03 05:06 PM
CLARK IAN TDirectorSep 01Sale130.001,076139,8800Sep 03 05:06 PM
Eltoukhy HelmyCo-Chief Executive OfficerAug 13Option Exercise4.1823,92399,9981,851,686Aug 17 07:02 PM
Talasaz AmirAliCo-Chief Executive OfficerAug 13Option Exercise4.1823,92399,9981,749,345Aug 17 07:02 PM
MERESMAN STANLEY JDirectorAug 10Option Exercise5.944,93429,3088,993Aug 12 05:08 PM
MERESMAN STANLEY JDirectorAug 10Sale114.314,934564,0064,059Aug 12 05:08 PM
MERESMAN STANLEY JDirectorJul 12Option Exercise5.944,93429,3088,993Jul 14 05:01 PM
MERESMAN STANLEY JDirectorJul 12Sale124.274,934613,1484,059Jul 14 05:01 PM
CLARK IAN TDirectorJun 29Option Exercise63.835,916377,61310,559Jul 01 05:04 PM
CLARK IAN TDirectorJun 29Sale130.0010,5591,372,6700Jul 01 05:04 PM
MERESMAN STANLEY JDirectorJun 10Option Exercise5.944,93429,3088,993Jun 14 05:02 PM
MERESMAN STANLEY JDirectorJun 10Sale113.604,934560,5024,059Jun 14 05:02 PM
MERESMAN STANLEY JDirectorMay 10Option Exercise5.944,93429,3088,993May 12 05:22 PM
MERESMAN STANLEY JDirectorMay 10Sale133.014,934656,2714,059May 12 05:22 PM
Kaul SamirDirectorMay 05Sale142.855,000714,24214,943May 07 04:41 PM
CLARK IAN TDirectorApr 26Option Exercise4.185382,2495,181Apr 28 06:16 PM
CLARK IAN TDirectorApr 26Sale159.9253886,0374,643Apr 28 06:16 PM
Eltoukhy HelmyChief Executive OfficerApr 26Sale160.01751120,1671,827,763Apr 26 05:35 PM
Eltoukhy HelmyChief Executive OfficerApr 23Sale160.127,3881,182,9931,828,514Apr 26 05:35 PM
Eltoukhy HelmyChief Executive OfficerApr 21Sale151.7656,3588,552,6901,835,902Apr 22 06:43 PM
Eltoukhy HelmyChief Executive OfficerApr 20Sale150.7516,0072,413,0001,892,260Apr 22 06:43 PM
Eltoukhy HelmyChief Executive OfficerApr 19Sale152.9750,9327,790,9141,908,267Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 16Sale158.3451,1238,094,7211,959,199Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 15Sale158.85157,10724,957,0962,010,322Apr 19 07:14 PM
Eltoukhy HelmyChief Executive OfficerApr 14Sale156.5460,9829,545,8742,167,429Apr 14 06:08 PM
Eltoukhy HelmyChief Executive OfficerApr 13Sale156.72105,80616,581,4452,228,411Apr 14 06:08 PM
MERESMAN STANLEY JDirectorApr 12Option Exercise5.944,93429,3088,993Apr 14 06:06 PM
Eltoukhy HelmyChief Executive OfficerApr 12Sale154.5972,86111,263,8462,334,217Apr 14 06:08 PM
MERESMAN STANLEY JDirectorApr 12Sale153.744,934758,5334,059Apr 14 06:06 PM
Eltoukhy HelmyChief Executive OfficerApr 09Sale156.8660,9969,567,6782,407,078Apr 09 05:51 PM
Eltoukhy HelmyChief Executive OfficerApr 08Sale160.78122,84619,751,1862,468,074Apr 09 05:51 PM
Eltoukhy HelmyChief Executive OfficerApr 07Sale158.6136,8435,843,6842,590,920Apr 09 05:51 PM
Kaul SamirDirectorApr 05Sale158.565,000792,78919,943Apr 07 05:08 PM
CLARK IAN TDirectorMar 25Option Exercise4.185382,2495,181Mar 29 05:13 PM
CLARK IAN TDirectorMar 25Sale132.0953871,0644,643Mar 29 05:13 PM
MERESMAN STANLEY JDirectorMar 10Option Exercise5.944,93429,3088,993Mar 12 05:25 PM
MERESMAN STANLEY JDirectorMar 10Sale137.854,934680,1524,059Mar 12 05:25 PM
CLARK IAN TDirectorFeb 25Option Exercise4.185382,2495,181Mar 01 05:09 PM
CLARK IAN TDirectorFeb 25Sale154.0053882,8524,643Mar 01 05:09 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale168.466,6131,114,042470,800Feb 12 08:21 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale166.5623,5293,918,993477,413Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 11Sale166.98202,25133,771,3581,725,422Feb 12 08:19 PM
MERESMAN STANLEY JDirectorFeb 10Option Exercise5.944,93429,3088,993Feb 12 04:53 PM
Talasaz AmirAliChairman, President and COOFeb 10Sale160.908,6891,398,054500,942Feb 12 08:19 PM
Talasaz AmirAliChairman, President and COOFeb 10Sale160.9058,3049,381,0701,927,673Feb 12 08:19 PM
MERESMAN STANLEY JDirectorFeb 10Sale162.714,934802,8114,059Feb 12 04:53 PM
Talasaz AmirAliChairman, President and COOFeb 09Sale162.9315,0692,455,231509,631Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 09Sale162.93101,11116,474,2641,985,632Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 08Sale162.3913,8172,243,679524,700Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 08Sale162.3992,70815,054,4272,086,743Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 05Sale161.7630,0844,866,462538,517Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 05Sale161.76201,86132,653,5292,179,451Feb 09 07:21 PM
Talasaz AmirAliChairman, President and COOFeb 04Sale158.756,9701,106,512568,601Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 04Sale158.7547,0537,469,8352,381,312Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 03Sale158.7211,4621,819,222575,571Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 03Sale158.7276,91512,207,7722,428,365Feb 05 05:03 PM
Talasaz AmirAliChairman, President and COOFeb 02Sale158.1619,4983,083,832587,033Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 02Sale158.16130,89320,702,2292,622,883Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 01Sale154.4114,2692,203,337606,531Feb 03 07:33 PM
Talasaz AmirAliChairman, President and COOFeb 01Sale154.4195,74414,784,2392,753,776Feb 03 07:33 PM
CLARK IAN TDirectorJan 25Option Exercise4.185382,2495,181Jan 27 05:00 PM
CLARK IAN TDirectorJan 25Sale162.0053887,1564,643Jan 27 05:00 PM
Eltoukhy HelmyChief Executive OfficerJan 25Sale157.2658,8119,248,6422,627,763Jan 26 05:40 PM
Eltoukhy HelmyChief Executive OfficerJan 22Sale159.91102,07516,322,4042,686,574Jan 26 05:40 PM
Eltoukhy HelmyChief Executive OfficerJan 21Sale162.01173,20628,061,5252,788,649Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 20Sale163.5344,5287,281,807365,775Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 20Sale163.53167,66327,418,4732,961,855Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 19Sale160.12103,71716,606,912410,303Jan 21 07:46 PM
Eltoukhy HelmyChief Executive OfficerJan 15Sale158.39150,00023,758,873514,020Jan 19 04:59 PM
MERESMAN STANLEY JDirectorJan 11Option Exercise5.944,93429,3088,993Jan 13 04:40 PM
MERESMAN STANLEY JDirectorJan 11Sale142.004,934700,6284,059Jan 13 04:40 PM
CLARK IAN TDirectorJan 04Option Exercise4.182,69011,2447,333Jan 06 04:18 PM
CLARK IAN TDirectorJan 04Sale129.232,690347,6294,643Jan 06 04:18 PM
Eltoukhy HelmyChief Executive OfficerJan 01Option Exercise0.00565,19203,408,645Jan 05 08:44 PM
Talasaz AmirAliChairman, President and COOJan 01Option Exercise0.00565,19203,128,647Jan 05 08:42 PM
CLARK IAN TDirectorDec 28Option Exercise4.185382,2495,181Dec 30 04:30 PM
CLARK IAN TDirectorDec 28Sale135.0053872,6304,643Dec 30 04:30 PM
Talasaz AmirAliChairman, President and COODec 21Option Exercise4.1823,92399,9982,563,455Dec 23 04:50 PM
Eltoukhy HelmyChief Executive OfficerDec 16Option Exercise4.1823,92399,9982,843,453Dec 18 04:57 PM
MERESMAN STANLEY JDirectorDec 10Option Exercise5.944,95429,4279,013Dec 14 04:52 PM
MERESMAN STANLEY JDirectorDec 10Sale125.444,954621,4304,059Dec 14 04:52 PM
CLARK IAN TDirectorDec 03Option Exercise4.182,69011,2447,333Dec 07 05:01 PM
CLARK IAN TDirectorDec 03Sale120.002,690322,8004,643Dec 07 05:01 PM
CLARK IAN TDirectorNov 25Option Exercise4.185382,2495,181Nov 27 02:48 PM
CLARK IAN TDirectorNov 25Sale113.2853860,9454,643Nov 27 02:48 PM
MERESMAN STANLEY JDirectorNov 10Option Exercise5.945,00029,7009,059Nov 12 05:07 PM
MERESMAN STANLEY JDirectorNov 10Sale110.305,000551,5004,059Nov 12 05:07 PM
CLARK IAN TDirectorNov 03Option Exercise4.182,69011,2447,333Nov 05 05:32 PM
CLARK IAN TDirectorNov 03Sale105.282,690283,2034,643Nov 05 05:32 PM
Talasaz AmirAliChairman, President and COOOct 27Sale107.1875,8518,129,541620,800Oct 27 06:08 PM
CLARK IAN TDirectorOct 26Option Exercise4.185382,2495,181Oct 28 04:32 PM
CLARK IAN TDirectorOct 26Sale104.0353855,9684,643Oct 28 04:32 PM
Talasaz AmirAliChairman, President and COOOct 26Sale105.024,613484,472696,651Oct 27 06:08 PM
Talasaz AmirAliChairman, President and COOOct 23Sale105.1513,1361,381,315701,264Oct 27 06:08 PM